Creating a Better Infusion Care Experience at Home

For people living with chronic conditions, specialty infusion care is rarely a one-time event. It is a recurring, essential part of ongoing treatment. This often means repeated trips to outpatient centers, time away from work and family, and bills that are hard to understand.

For employers, specialty drug spending, which includes many infused therapies, is rising faster than overall medical costs.¹ A meaningful share of that spending is not the drug itself, but where it is administered. Traditional reimbursement models and facility fees can push the allowed amount for a single infusion claim ​up ​to​​​​​​ 400% or more above the drug's actual cost.²

Specialty infusion is also one of the least transparent areas of healthcare spend. Drug markups, facility fees, and administration charges get bundled into a single medical claim, making specialty infusion easy to miss as a distinct line item. For the Member, the experience is often stressful, disruptive, and impersonal, even though many of these infusions can safely be delivered at home.

This is why Transcarent is reimagining the specialty infusion experience by incorporating this care category into the Transcarent Experience Store through a new partnership with Leap. Leap offers the only transparent specialty infusion benefit that removes hidden drug markups for self-funded employers while improving the Member experience, adherence, and outcomes through care delivered at home or in other lower-cost settings.

Employers now have a transparent pass-through pricing model and coordinated support through Leap's dedicated Care Guides, who handle prior authorization, drug procurement, scheduling, and follow-up. Members get access to a human-centered infusion experience that's connected to the rest of their care, with clinical support to determine when home is the safest, most convenient, and most cost-effective site of care.

Why Employers Should Care About Infusion

When infusion sits outside a Member's care journey, the Member ends up navigating between specialists, infusion centers, pharmacies, and benefits teams on their own. Delays become more likely. Adherence suffers, and the risk of complications and avoidable costs rises.

For benefits leaders, HR decision-makers, and consultants, this is the real issue: specialty infusion is not only expensive but also disconnected, resulting in care that is harder to use and manage.

Infusion therapy should be part of a continuous, connected care journey.

WayFinding Connects Infusion to the Care Journey

We paired Transcarent’s agentic AI-powered WayFinding® platform with Leap's specialty infusion benefit so Members have an even more connected experience. They have a better understanding of what comes next, where to go, and how treatment fits into their overall care plan. Members can Just Ask Transcarent® and be guided to the right next step, in-network care, and a clear answer on which site of care is right for them. Most often, that means home. In fact, 95% of Members on infusion therapy through Leap choose home infusion when given the choice. As a result, they are more comfortable, more likely to complete therapy, and at a lower risk of hospital infection exposure.

Because the WayFinding platform keeps infusion connected to other Transcarent Care Experiences, including Cancer Care and Surgery Care, it becomes part of a comprehensive experience rather than another disconnected encounter. By connecting scheduling, support, and follow-up, WayFinding also helps reduce delays, improve adherence, and make it easier for Members to move through treatment with confidence.

A Vetted Infusion Partner with Measurable ROI

Adding Leap to the Transcarent Experience Store gives employers a vetted, integrated specialty infusion partner that Members can access in One Place™. Where clinically appropriate, Members can receive infusions in safe, convenient, lower-cost settings while having an elevated experience. Employers receive transparent, pass-through drug pricing with no hidden markups, end-to-end coordination with one contract and one bill, and national coverage across all 50 states.

The financial impact is immediate. Employers can achieve up to 60% savings on specialty drug costs and up to $3 million in net savings per 10,000 Members.³ Leap's Net Promoter Score of 92 reflects what Members experience on the other side of those numbers: an infusion benefit that's easier, faster, and more supportive than the alternative.

Discover Connected, Clinically Led Infusion Care

Specialty infusion has been a high-cost blind spot in employer benefits for a long time. With Transcarent and Leap, it becomes part of a connected care category that moves care to safer, lower-cost settings, improves outcomes through coordinated clinical support, and delivers an experience that fits into Members’ lives.

Contact us to see how a Leap and Transcarent infusion strategy could support your employee population.

Sources

¹ PwC, Medical cost trend: Behind the numbers.

² Hospital Prices for Physician-Administered Drugs for Patients with Private Insurance.

³ Leap Health internal analysis based on client and prospect claims data.